Biotechnology from bench to business

• Follow GEN on:
• Log In / Register | Subscribe

Current Issue

Top Keywords

• ADME/Tox
• Angiogenesis
• Apoptosis
• Antibodies
• Biomanufacturing
• Biomarkers
• Bioreactors
• Biosimilars
• Biotherapeutics
• Cancer
• Cancer Stem Cells
• Cell Culture
• Cell-Based Assays
• Chromatography
• Contract Manufacturing
• Gene Expression
• Genetics
• Genomics
• Glycan Analysis
• HPLC
• Immunoassay
• Liquid Handling
• mAb Production
• mAb Therapeutics
• Microarrays
• Multiplexing
• Next-Generation Sequencing
• Peptide Therapeutics
• PCR
• Pharmacokinetics
• Protein Characterization
• Protein Expression
• Protein Production
• Protein Therapeutics
• qPCR
• Reagents
• RNA-Seq
• Sequencing
• Single-Use Systems
• Small Molecules
• Stem Cells
• Transfection
• Vaccines

NIH - Related Content

• GEN Articles
• Insight & Intelligence™
• GEN News Highlights
• GEN Podcasts
• BLOG Biotech
• Best Of The Web

GEN articles

• Point of View: Maintaining a Steadfast Commitment to NIH Funding
  U.S. Senator from Kansas Offers Amendment to Restore Funding to the NIH Budget
• Insight & Intelligence™: Syn Bio Delivers Cool Tools but Drugs Are a Ways Off
  
• Point of View: Revamping Research Funding
  Drastic Measures Needed to Make Science a Compelling Career Choice for the Best and the Brightest
• Point of View: NCATS Could Mitigate Pharma Valley of Death
  National Center for Advancing Translational Sciences Essential to Capitalize on Basic Research
• Point of View: NIH Pharma Co. Is a Bad Idea
  Remedy for the Shrinking Number of New Medicines Is Not More Gov't Involvement

• MORE NIH RELATED GEN ARTICLES

Insight & intelligence™

• NIH Expects to Have New Policies for Research Using Chimpanzees Next Year
  March 16, 2012
  A working group has been established to review IOM’s findings and make suggestions for implementation.
• NIH, NSF to Leverage 2013 Budget Toward More Translational Medicine
  February 15, 2012
  Under President Barack Obama’s proposal, NIH’s spending remains flat and NSF’s goes up 4.8%.
• Despite Flat Budget, NIH’s TRND Program Tries to Spark Interest in Rare and Neglected Diseases
  January 31, 2012
  With 14 approved programs in total, TRND has progressed two into clinical development.
• Review of NIH Grants in 2011 Shows Top Five Recipients Same as Last Year’s
  January 10, 2012
  Johns Hopkins University came in first with $637.552 million, 4% more than last year.
• NIH Spending Barely Budges, CDC Stays Flat as Congress Finalizes FY 2012 Budget
  December 19, 2011
  NIH will see a 1% increase and CDC a 0.6% increase over FY ’11 under a $1 trillion spending plan passed by the House and Senate.

• MORE NIH RELATED INSIGHT & INTELLIGENCE™

GEN news highlights

• NIH’s NCATS Establishes $20M Collaborative Drug Repositioning Initiative
  
• DiaKine Awarded $2.1M in Grants from NIH, Iacocca Foundation for Diabetes Therapy
  
• Poll Respondents Undecided About Helpfulness of President's Proposed Budgets for NIH, NSF
  
• NIH’s TRND Program Will Boost Rare and Neglected Disease Drug Development, GEN Voters Say
  
• NIH Will Pay for Salary Cap with GEN Poll Predicting Researchers Will Migrate to Industry
  

• MORE NIH RELATED GEN NEWS HIGHLIGHTS

GEN podcasts

• NEW GENETIC CLUES TO BLOOD PRESSURE REGULATION
  - Interview with Daniel Levy, M.D., Director of the National Heart, Lung, and Blood Institute's Framingham Heart Study and Professor of Medicine at the Boston University School of Medicine

• MORE NIH RELATED GEN PODCASTS

BLOG biotech

• Getting the Full Story: How We Waste Research
  
• Whence Goeth NIH Investigators?
  
• The Next Big Thing: An Obesity Initiative from the NIH
  
• H3Africa, a Refreshingly Ethical Research Endeavor in Africa
  
• Financial Bailout for the Little Guys in Research
  

• VIEW BY SUBJECT | MORE NIH RELATED BLOG BIOTECH

Best of the web

• 4Researchers.org
  

• MORE NIH RELATED BEST OF THE WEB

Home | Terms of Use | Privacy Statement | Legal